Hydrocodone Rescheduling and Opioid Prescribing Disparities in Breast Cancer Patients.

Cancers (Basel) · 2025 · PMC12248469 · PMID 40647445

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

did not reach statistical significancep = 0.087so close (0.05 < p ≤ 0.1)

Among non-dual-eligible patients, there was a moderate increase in non-hydrocodone opioid use after the policy change (AOR = 1.22; 95% CI: 0.97–1.53) with a reduction of 8 absolute percentage points, although this result did not reach statistical significance ( p = 0.087).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.